Sanam Loghavi, Associate Professor of Pathology at MD Anderson Cancer Center, Medical Director of ECOG-ACRIN Leukemia Bank and Editor in Chief of Image Bank at the American Society of Hematology, shared a post on X:
“With 2 FDAOncology approved menin-inhibitors, ongoing clinical trials and more approvals on the horizon, it’s more important than ever to accurately identify pts who may benefit from these agents. Come to my talk if you’re at Association for Molecular Pathology
I’ll go over testing strategies to identify menin-i-sensitive genotypes in AML A huge thanks to Association for Molecular Pathology J. Bryan and the organizers for the invitation.”
Other Articles Featuring Sanam Loghavi on OncoDaily.
